PharmAust Ltd Receives World Wide Attention., page-16

Perfect analysis Elit.

The other matter that may be raised as well, is market forces.

Good old supply and demand.

This may work out as a double whammy for PharmAust.

Successful canine trials - Lanco will want to take the option - and being a demand for the Elanco Option - will drive the option in PharmAust's favor - on many fronts.

The secondary spin off will see a demand in PharmAust's shares.

Currently. demand is practically nil.
Come the negotiation period, interest will increase and so will demand - hence the SP.

PharmAust just has to clear the last hurdle in the reformulation and the can hit the market hard.

As always
Best
MM